Efficacy and safety of bimatoprost in patients with Elevated intraocular pressure: A 30-day comparison with latanoprost

Survey of Ophthalmology

Volumn 45, Issue SUPPL. 4, 2001, Pages

  DuBiner, Harvey ^a   Cooke, David ^b   Dirks, Monte ^c   Stewart, William C ^d   VanDenburgh, Amanda M ^e   Felix, Carlos ^e  

^a Clayton Eye Center   (United States)

^b Great Lakes Eye Care   (United States)

^c BROOKE ARMY MEDICAL CENTER   (United States)

^d University of South Carolina   (United States)

^e ALLERGAN INC   (United States)

Author keywords

AGN 192024; Bimatoprost; Glaucoma; Latanoprost; Lumigan ; Ocular hypertension; Prostamide

Indexed keywords

ANTIGLAUCOMA AGENT; BIMATOPROST; LATANOPROST; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPEREMIA; INTRAOCULAR PRESSURE ABNORMALITY; MALE; MULTICENTER STUDY; OPEN ANGLE GLAUCOMA; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AMIDES; ANTIHYPERTENSIVE AGENTS; CONJUNCTIVA; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA, OPEN-ANGLE; HEMODYNAMIC PROCESSES; HUMANS; HYPEREMIA; INTRAOCULAR PRESSURE; LIPIDS; MALE; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS F, SYNTHETIC; SAFETY; TONOMETRY, OCULAR;

EID: 0034756982     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6257(01)00212-0     Document Type: Article

References (20)

1. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures
2. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol
3. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: A six-month masked, multicenter trial in the United States
4. Rank transformations as a bridge between parametric and nonparametric studies
5. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects
6. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma
7. Preface
8. Fluctuations of intraocular pressure during the day in open-angle glaucoma, normal-tension glaucoma and normal subjects
9. Intraocular pressure-dependent progression: A 15-year follow-up
10. Target pressure - Glaucomatologists holey grail
11. The advanced glaucoma intervention study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration
12. A one-month dose-response study of AGN 192024, a novel antiglaucoma agent, in patients with elevated intraocular pressure
13. A novel ocular hypotensive lipid: Initial safety and efficacy of AGN 192024
14. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension
15. Replacement of the carboxylic acid group of prostaglandin F2α with a hydroxyl or methoxy substituent provides biologically unique compounds
16. Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2
17. Target pressures in glaucoma